Fit-Joints: Getting Fit for Hip or Knee Replacement (Fit-Joints)

March 17, 2023 updated by: Alexandra Papaioannou, McMaster University

Fit-Joints: Getting Fit for Hip or Knee Replacement, A Pilot Randomized Control Trial

Osteoarthritis leads to reduced independence and quality of life. Total hip replacement is a successful and cost-effective surgical intervention to relieve pain and improve functioning in patients with osteoarthritis. Research has shown that preoperative health status strongly predicts outcomes including physical function and hospitalization length after hip replacement surgery. Frail patients, in particular, are at greater risk of poor postoperative outcomes and could potentially benefit from interventions targeting an improvement in their health status prior to undergoing a hip or knee replacement surgery. Partnering with the YMCA and a multi-disciplinary team of healthcare providers, this pilot trial will examine the feasibility of a multi-modal intervention for frail patients that includes a supervised exercise program, vitamin D and protein supplementation, and a medication review. The results of this feasibility study will guide the design of a future multi-centre study, which if successful, could be developed into a routine model of care that is implemented in joint replacement programs across Ontario and ultimately improving the lives of frail seniors undergoing hip or knee replacement.

Study Overview

Detailed Description

Study Design: The proposed study is a pilot randomized controlled trial comparing a pre-operative multi-modal intervention and standard care among pre-frail/frail patients undergoing total hip or knee replacement surgery. Pre-frail (score of 1 or 2) or frail (score of 3-5; Fried Frailty Phenotype) patients, ≥ 60 years undergoing elective unilateral total hip or knee replacement after at least 3 months will be recruited from the practices of 8 orthopedic surgeons (Hamilton Arthroplasty Group).

A research assistant (RA) will conduct the eligibility screening at the Regional Joint Assessment Program (Hamilton Health Sciences) and St. Joseph's Healthcare, Hamilton, ON during an appointment (3-9 months prior to surgery). Patients with renal insufficiency, a neuromuscular disorder, active cancer or any inflammatory arthritis will be excluded.

Stratified block randomization will be used to randomly allocate participants to the intervention or usual care arms of the study. The allocation sequence will be computer generated using Statistical Analysis Software (SAS) 9.3. Once the study RA confirms the patient's eligibility, and obtain consent, the RA will inform the research coordinator (RC) who will randomize the participant using Red Cap randomization list. Then the RC will call the participants to inform them if they fall in the intervention or control group and arrange the first visit.

Multi-Modal Frailty Intervention (3-9 months). Exercise: A Registered physiotherapist will develop an individualized exercise program and schedule appointments with the patient at home including goal setting discussion. Participants will be offered free YMCA membership to participate in the IN Motion program.The IN Motion program is designed for older adults and include gentle fit, hydrotherapy and walk fit classes along with health education sessions. Participants will be taught how to monitor their own heart rate and level of exertion using the Borg Rating of Perceived Exertion 10-point Scale. All participants will be encouraged to exercise at least 3 times per week for 45-60 minutes either at home and/or at YMCA IN Motion classes. The home exercise will incorporate aerobic, resistance training, flexibility and balance components. Patients will be provided with and asked to keep an exercise log-book.

Cognitive-behavioral Change Strategy and education:

Cognitive Behavioral Change Strategies (CBCS) may be an effective way to facilitate coaching strategies to increase participant exercise levels. In the current study, modules will be presented to participants in the event that they express any barriers to exercise. These barriers will vary based on: the individual, environment, and previous exercise behaviors. Throughout the intervention, CBCS will be performed and administered by the physiotherapist prior to the participants scheduled surgery. The administration of the modules will be dependent on the challenges that the participants express in relation to exercise (i.e., lack of time, motivation, social support, etc.). A definition of each strategy will be given to the participant; the physiotherapist will then work through a worksheet with the participant.

Protein Supplement: Participants will be provided with 1-2 daily supplements (containing 20-40 gram protein, 1.5 g β-Hydroxy β-Methylbutyrate /serving) to be taken with a meal or on activity days within 3-hours of exercise.

Vitamin D: All participants in the intervention arm will be provided with a supply of Vitamin D3 (1000 IU/day tablets) for the duration of the intervention period.

Medication Review: After randomization, a geriatrician will review the medications for patients in the intervention arm and provide written recommendations to the participant's family doctor.

Control arm: Patients in the control arm will receive usual care which may include the recommendation to attend fitness classes before surgery; however these patients will not receive the more intensive assessment/intervention of the physiotherapist and other intervention components. Control participants will be asked pre-operatively and post-operatively to indicate whether or not they exercise, take protein or vitamin supplements.

For participants in intervention and control groups will, 1) be monitored for their YMCA attendance and 2) be instructed on the completion a dietary intake log that indicate the type of food and amount over a four-day period in order to calculate energy and micronutrient consumption. Then a RA will call the participants to collect their food intake.

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's Healthcare Hamilton
      • Hamilton, Ontario, Canada, L8M1W9
        • McMaster University - Juravinski Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Participants will be included if they are: 1) ≥ 60 years old; 2) pre-frail (score of 1 or 2) or frail (score of 3-5; Fried Frailty Phenotype); 3) receiving elective unilateral hip or knee replacement; and 4) waiting time to surgery is estimated to be between 3 to 9 months. Participants will be excluded if reported having: 1) renal insufficiency (due to potential contraindication of additional protein); 2) neuromuscular disorder; 3) active cancer; or 4) any inflammatory arthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Care

Patients in the control arm will receive usual care which may include the recommendation to attend fitness classes before surgery, however these patients will not receive the more intensive assessment/intervention of the physiotherapist and other intervention components. Control participants will be asked pre-operatively and post-operatively to indicate whether or not they exercise, take protein or vitamin supplements.

For participants in intervention and control groups will, 1) we will monitor the YMCA attendance and 2) participants will be instructed on the completion a dietary intake log (including days of the week and weekend days) that indicate the type of food and amount over a four-day period in order to calculate energy and micronutrient consumption.

Patients in the control arm will receive usual care which may include the recommendation to attend fitness classes before surgery, however these patients will not receive the more intensive assessment/intervention of the physiotherapist and other intervention components. Control participants will be asked pre-operatively and post-operatively to indicate whether or not they exercise, take protein or vitamin supplements.

For participants in intervention and control groups will, 1) we will monitor the YMCA attendance and 2) participants will be instructed on the completion a dietary intake log (including days of the week and weekend days) that indicate the type of food and amount over a four-day period in order to calculate energy and micronutrient consumption.

Experimental: Multi-Modal Frailty Intervention

Exercise: A physiotherapist will develop an individualized exercise program and schedule appointments with patients at a physiotherapist clinic. Participants will be offered free YMCA membership.

Cognitive-behavioural Change Strategy(CBCS) and education: Throughout the intervention, CBCS and education about exercise, hip or knee arthroplasty and osteoarthritis will be administered.

Protein Supplement: Participants will be provided with 1-2 daily supplements (containing 20-40 gram protein, 1.5 g β-Hydroxy β-Methylbutyrate /serving) to be taken with a meal or on activity days within 3-hours of exercise.

Vitamin D: All participants in the intervention arm will be provided with a supply of Vitamin D3 (1000 IU/day tablets) for the duration of the intervention period.

Medication Review: A geriatrician will review the medications for patients in the intervention arm.

Patients in the control arm will receive usual care which may include the recommendation to attend fitness classes before surgery, however these patients will not receive the more intensive assessment/intervention of the physiotherapist and other intervention components. Control participants will be asked pre-operatively and post-operatively to indicate whether or not they exercise, take protein or vitamin supplements.

For participants in intervention and control groups will, 1) we will monitor the YMCA attendance and 2) participants will be instructed on the completion a dietary intake log (including days of the week and weekend days) that indicate the type of food and amount over a four-day period in order to calculate energy and micronutrient consumption.

Exercise: A physiotherapist will develop an individualized exercise program and schedule appointments with the patient at a physiotherapist clinic. Participants will be offered free YMCA membership.

Cognitive-behavioural Change Strategy(CBCS) and education: Throughout the intervention, CBCS and education about exercise, hip or knee arthroplasty and osteoarthritis will be administered.

Protein Supplement: Participants will be provided with 1-2 daily supplements (containing 20-40 gram protein, 1.5 g β-Hydroxy β-Methylbutyrate /serving) to be taken with a meal or on activity days within 3-hours of exercise.

Vitamin D: All participants in the intervention arm will be provided with a supply of Vitamin D3 (1000 IU/day tablets) for the duration of the intervention period.

Medication Review: A geriatrician will review the medications for patients in the intervention arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment Rate
Time Frame: Through study completion, an average of two years
4 patient/month
Through study completion, an average of two years
Retention Rate
Time Frame: Through study completion, an average of two years
target ≥ 70%
Through study completion, an average of two years
Data Collection completion
Time Frame: Through study completion, an average of two years
target ≥ 70%
Through study completion, an average of two years
Proportion of recruited patients
Time Frame: Through study completion, an average of two years
target ≥ 70%
Through study completion, an average of two years
Refusal Rate
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
target ≥ 70%
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op

Secondary Outcome Measures

Outcome Measure
Time Frame
GERAS Fit Frailty Index to measure frailty
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Oxford Hip or Knee Score to measure pain and function
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Sarc-F to measure sarcopenia
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
European Quality of Life-5 Dimensions to measure health related quality of life
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Mini-Cog Test to measure cognitive function
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Older Americans Resources and Services Questionnaire to measure basic and instrumental activity of daily life
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Number of Hospital admission (or readmissions)
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Number of visits to Healthcare providers
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Number of medications and supplements
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Discharge Destination
Time Frame: 6 weeks post-op and 6 months post-op
6 weeks post-op and 6 months post-op
Number of Falls
Time Frame: 1 week pre-op, 6 weeks post-op, 6 months post-op
1 week pre-op, 6 weeks post-op, 6 months post-op
Number of Adverse Events
Time Frame: 1 week pre-op, 6 weeks post-op, 6 months post-op
1 week pre-op, 6 weeks post-op, 6 months post-op
Serum 25-Hydroxy Vitamin D
Time Frame: Baseline and 6 weeks post-op
Baseline and 6 weeks post-op
Serum Pre-Albumin
Time Frame: Baseline and 6 weeks post-op
Baseline and 6 weeks post-op
Short Performance Physical Battery
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Fried Frailty Phenotype
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Length of stay after surgery
Time Frame: 6 weeks post-op, 6 months post-op
6 weeks post-op, 6 months post-op
Length of stay - rehabilitation
Time Frame: 6 weeks post-op, 6 months post-op
6 weeks post-op, 6 months post-op
Surgical Complications
Time Frame: 6 weeks post-op, 6 months post-op
6 weeks post-op, 6 months post-op
Number of ER visits
Time Frame: Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op
Baseline, 1 week pre-op, 6 weeks post-op, 6 months post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandra Papaioannou, MD,MSc, McMaster University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2016

Primary Completion (Actual)

December 31, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

August 9, 2016

First Submitted That Met QC Criteria

August 26, 2016

First Posted (Estimate)

August 31, 2016

Study Record Updates

Last Update Posted (Actual)

March 21, 2023

Last Update Submitted That Met QC Criteria

March 17, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Usual Care

Subscribe